Evidence map›Paper›PMID 26717198›Full record

Trial reportPloS one2015

Hydrogel-Forming Microneedle Arrays Allow Detection of Drugs and Glucose In Vivo: Potential for Use in Diagnosis and Therapeutic Drug Monitoring.

Ester Caffarel-Salvador, Aaron J Brady, Eyman Eltayib, Teng Meng, Ana Alonso-Vicente, Patricia Gonzalez-Vazquez, Barbara M Torrisi, Eva Maria Vicente-Perez, Karen Mooney, David S Jones and 5 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 165 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Swellable Microneedles in Drug Delivery and Diagnostics.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Development of a novel microneedle platform for biomarker assessment of atopic dermatitis patients.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  19. Article
  20. Advances in dermatological application of GelMA hydrogel microneedles.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ester Caffarel-SalvadorSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Aaron J BradySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Eyman EltayibSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Teng MengSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Ana Alonso-VicenteSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Patricia Gonzalez-VazquezSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Barbara M TorrisiSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Eva Maria Vicente-PerezSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Karen MooneySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
David S JonesSchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Steven E J BellSchool of Chemistry and Chemical Engineering, Queen's University Belfast, Stranmillis Road, Belfast, BT9 5AG, United Kingdom.
Colin P McCoySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Helen O McCarthySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
James C McElnaySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Ryan F DonnellySchool of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT97BL, United Kingdom.
Queen's University Belfast · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe, for the first time the use of hydrogel-forming microneedle (MN) arrays for minimally-invasive extraction and quantification of drug substances and glucose from skin in vitro and in vivo. MN prepared from aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride) (11.1% w/w) and poly(ethyleneglycol) 10,000 daltons (5.6% w/w) and crosslinked by esterification swelled upon skin insertion by uptake of fluid. Post-removal, theophylline and caffeine were extracted from MN and determined using HPLC, with glucose quantified using a proprietary kit. In vitro studies using excised neonatal porcine skin bathed on the underside by physiologically-relevant analyte concentrations showed rapid (5 min) analyte uptake. For example, mean concentrations of 0.16 μg/mL and 0.85 μg/mL, respectively, were detected for the lowest (5 μg/mL) and highest (35 μg/mL) Franz cell concentrations of theophylline after 5 min insertion. A mean concentration of 0.10 μg/mL was obtained by extraction of MN inserted for 5 min into skin bathed with 5 μg/mL caffeine, while the mean concentration obtained by extraction of MN inserted into skin bathed with 15 μg/mL caffeine was 0.33 μg/mL. The mean detected glucose concentration after 5 min insertion into skin bathed with 4 mmol/L was 19.46 nmol/L. The highest theophylline concentration detected following extraction from a hydrogel-forming MN inserted for 1 h into the skin of a rat dosed orally with 10 mg/kg was of 0.363 μg/mL, whilst a maximum concentration of 0.063 μg/mL was detected following extraction from a MN inserted for 1 h into the skin of a rat dosed with 5 mg/kg theophylline. In human volunteers, the highest mean concentration of caffeine detected using MN was 91.31 μg/mL over the period from 1 to 2 h post-consumption of 100 mg Proplus® tablets. The highest mean blood glucose level was 7.89 nmol/L detected 1 h following ingestion of 75 g of glucose, while the highest mean glucose concentration extracted from MN was 4.29 nmol/L, detected after 3 hours skin insertion in human volunteers. Whilst not directly correlated, concentrations extracted from MN were clearly indicative of trends in blood in both rats and human volunteers. This work strongly illustrates the potential of hydrogel-forming MN in minimally-invasive patient monitoring and diagnosis. Further studies are now ongoing to reduce clinical insertion times and develop mathematical algorithms enabling determination of blood levels directly from MN measurements.

Indexed as

Drug MonitoringGlucoseHydrogel, Polyethylene Glycol DimethacrylateMicroinjectionsPharmaceutical PreparationsAnimalsAnimals, NewbornCaffeineHealthy VolunteersHumansRatsReproducibility of ResultsSus scrofaTheophyllineCaffeineGlucoseHydrogel, Polyethylene Glycol DimethacrylatePharmaceutical PreparationsTheophylline

Identifiers

PMID26717198
PMCPMC4699208
OpenAlexW2212254347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.